InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
December 17, 2025 20:48 ET | Source: InnoCare Pharma BEIJING, Dec. 17,…
Kia EV5 WKNDR Spontaneous Escape Enabler Debuts at Guangzhou Auto Show
EV5 WKNDR created by Kia Design China team for a global audienceConcept…
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
October 19, 2025 08:00 ET | Source: RAPT Therapeutics, Inc. SOUTH SAN…
